The intracellular bacterial pathogen Francisella tularensis causes serious infectious disease in humans and animals. Moreover, F. tularensis, a highly infectious pathogen, poses a major concern for the public as a bacterium classified under Category A of bioterrorism agents. Unfortunately, research has so far failed to develop effective vaccines, due in part to the fact that the pathogenesis of intracellular bacteria is not fully understood and in part to gaps in our understanding of innate immune recognition processes leading to the induction of adaptive immune response. Recent evidence supports the concept that immune response to external stimuli in the form of bacteria is guided by the primary interaction of the bacterium with the host cell. Based on data from different Francisella models, we present here the basic paradigms of the emerging innate immune recognition concept. According to this concept, the type of cell and its receptor(s) that initially interact with the target constitute the first signaling window; the signals produced in the course of primary interaction of the target with a reacting cell act in a paracrine manner; and the innate immune recognition process as a whole consists in a series of signaling windows modulating adaptive immune response. Finally, the host, in the strict sense, is the interacting cell.

Department of Molecular Pathology and Biology Faculty of Military Health Sciences University of Defence Hradec Kralove Czechia

Zobrazit více v PubMed

Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K. A., Hornung V. (2009). RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10, 1065–1072. 10.1038/ni.1779 PubMed DOI PMC

Abplanalp A. L., Morris I. R., Parida B. K., Teale J. M., Berton M. T. (2009). TLR-dependent control of PubMed DOI PMC

Ancuta P., Pedron T., Girard R., Sandström G., Chaby R. (1996). Inability of the PubMed PMC

Arancibia S. A., Beltrán C. J., Aguirre I. M., Silva P., Peralta A. L., Malinarich F., et al. (2007). Toll-like receptors are key participants in innate immune responses. Biol. Res. 40, 97–112. 10.4067/S0716-97602007000200001 PubMed DOI

Ashtekar A. R., Zhang P., Katz J., Deivanayagam C. C., Rallabhandi P., Vogel S. N., et al. (2008). TLR4-mediated activation of dendritic cells by the heat shock protein DnaK from PubMed DOI PMC

Ayala J. M., Yamin T. T., Egger L. A., Chin J., Kostura M. J., Miller D. K. (1994). IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J. Immunol. 153, 2592–2599. PubMed

Balagopal A., MacFarlane A. S., Mohapatra N., Soni S., Gunn J. S., Schlesinger L. S. (2006). Characterization of the receptor-ligand pathways important for entry and survival of PubMed DOI PMC

Barel M., Charbit A. (2014). Detection of the interaction between host and bacterial proteins: eukaryotic nucleolin interacts with PubMed DOI

Barel M., Hovanessian A. G., Meibom K., Briand J. P., Dupuis M., Charbit A. (2008). A novel receptor - ligand pathway for entry of PubMed DOI PMC

Barel M., Meibom K., Charbit A. (2010). Nucleolin, a shuttle protein promoting infection of human monocytes by PubMed DOI PMC

Barker J. R., Koestler B. J., Carpenter V. K., Burdette D. L., Waters C. M., Vance R. E., et al. (2013). STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during PubMed DOI PMC

Bencurova E., Kovac A., Pulzova L., Gyuranecz M., Mlynarcik P., Mucha R., et al. (2015). Deciphering the protein interaction in adhesion of PubMed DOI

Ben Nasr A., Haithcoat J., Masterson J. E., Gunn J. S., Eaves-Pyles T., Klimpel G. R. (2006). Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of PubMed DOI

Bosio C. M., Bielefeldt-Ohmann H., Belisle J. T. (2007). Active suppression of the pulmonary immune response by PubMed DOI

Bosio C. M., Dow S. W. (2005). PubMed DOI

Botos I., Segal D. M., Davies D. R. (2011). The structural biology of Toll-like receptors. Structure 19, 447–459. 10.1016/j.str.2011.02.004 PubMed DOI PMC

Bourdonnay E., Henry T. (2016). Catch me if you can. Elife 5:e14721. 10.7554/eLife.14721 PubMed DOI PMC

Bradburne C. E., Verhoeven A. B., Manyam G. C., Chaudhry S. A., Chang E. L., Thach D. C., et al. (2013). Temporal transcriptional response during infection of type II alveolar epithelial cells with PubMed DOI PMC

Budak G., Eren Ozsoy O., Aydin Son Y., Can T., Tuncbag N. (2015). Reconstruction of the temporal signaling network in Salmonella-infected human cells. Front. Microbiol. 6:730. 10.3389/fmicb.2015.00730 PubMed DOI PMC

Burdette D. L., Monroe K. M., Sotelo-Troha K., Iwig J. S., Eckert B., Hyodo M., et al. (2011). STING is a direct innate immune sensor of cyclic di-GMP. Nature 478, 515–518. 10.1038/nature10429 PubMed DOI PMC

Burdette D. L., Vance R. E. (2013). STING and the innate immune response to nucleic acids in the cytosol. Nat. Immunol. 14, 19–26. 10.1038/ni.2491 PubMed DOI

Carvalho C. L., Lopes de Carvalho I., Zé-Zé L., Núncio M. S., Duarte E. L. (2014). Tularaemia: a challenging zoonosis. Comp. Immunol. Microbiol. Infect. Dis. 37, 85–96. 10.1016/j.cimid.2014.01.002 PubMed DOI PMC

Chase J. C., Celli J., Bosio C. M. (2009). Direct and indirect impairment of human dendritic cell function by virulent PubMed DOI PMC

Checroun C., Wehrly T. D., Fischer E. R., Hayes S. F., Celli J. (2006). Autophagy-mediated reentry of PubMed DOI PMC

Chen W., KuoLee R., Shen H., Bùsa M., Conlan J. W. (2004). Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A PubMed DOI

Chen W., Kuolee R., Shen H., Bùsa M., Conlan J. W. (2005). Toll-like receptor 4 (TLR4) plays a relatively minor role in murine defense against primary intradermal infection with PubMed DOI

Clemens D. L., Horwitz M. A. (2007). Uptake and intracellular fate of PubMed DOI

Clemens D. L., Lee B. Y., Horwitz M. A. (2004). Virulent and avirulent strains of PubMed DOI PMC

Clemens D. L., Lee B. Y., Horwitz M. A. (2005). PubMed DOI PMC

Cole L. E., Laird M. H., Seekatz A., Santiago A., Jiang Z., Barry E., et al. (2010). Phagosomal retention of PubMed DOI PMC

Cole L. E., Shirey K. A., Barry E., Santiago A., Rallabhandi P., Elkins K. L., et al. (2007). Toll-like receptor 2-mediated signaling requirements for PubMed DOI PMC

Collazo C. M., Sher A., Meierovics A. I., Elkins K. L. (2006). Myeloid differentiation factor-88 (MyD88) is essential for control of primary PubMed DOI

Culkin S. J., Rhinehart-Jones T., Elkins K. L. (1997). A novel role for B cells in early protective immunity to an intracellular pathogen, PubMed

Dai S., Rajaram M. V., Curry H. M., Leander R., Schlesinger L. S. (2013). Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for PubMed DOI PMC

Dotson R. J., Rabadi S. M., Westcott E. L., Bradley S., Catlett S. V., Banik S., et al. (2013). Repression of inflammasome by PubMed DOI PMC

Dueñas A. I., Aceves M., Orduña A., Díaz R., Sánchez Crespo M., García-Rodríguez C. (2006). PubMed DOI

Duncan D. D., Vogler A. J., Wolcott M. J., Li F., Sarovich D. S., Birdsell D. N., et al. (2013). Identification and typing of PubMed DOI

Eberl M., Hintz M., Reichenberg A., Kollas A. K., Wiesner J., Jomaa H. (2003). Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett. 544, 4–10. 10.1016/S0014-5793(03)00483-6 PubMed DOI

Eberl M., Jomaa H. (2003). A genetic basis for human gammadelta T-cell reactivity towards microbial pathogens. Trends Immunol. 24, 407–409. 10.1016/S1471-4906(03)00170-4 PubMed DOI

Elkins K. L., Bosio C. M., Rhinehart-Jones T. R. (1999). Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium PubMed PMC

Fernandes-Alnemri T., Yu J. W., Datta P., Wu J., Alnemri E. S. (2009). AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509–513. 10.1038/nature07710 PubMed DOI PMC

Fernandes-Alnemri T., Yu J. W., Juliana C., Solorzano L., Kang S., Wu J., et al. (2010). The AIM2 inflammasome is critical for innate immunity to PubMed DOI PMC

Forestal C. A., Benach J. L., Carbonara C., Italo J. K., Lisinski T. J., Furie M. B. (2003). PubMed DOI

Fortier A. H., Green S. J., Polsinelli T., Jones T. R., Crawford R. M., Leiby D. A., et al. (1994). Life and death of an intracellular pathogen: PubMed

Franchi L., Park J. H., Shaw M. H., Marina-Garcia N., Chen G., Kim Y. G., et al. (2008). Intracellular NOD-like receptors in innate immunity, infection and disease. PubMed DOI

Franchi L., Warner N., Viani K., Nuñez G. (2009). Function of Nod-like receptors in microbial recognition and host defense. Immunol. Rev. 227, 106–128. 10.1111/j.1600-065X.2008.00734.x PubMed DOI PMC

Geier H., Celli J. (2011). Phagocytic receptors dictate phagosomal escape and intracellular proliferation of PubMed DOI PMC

Gentry M., Taormina J., Pyles R. B., Yeager L., Kirtley M., Popov V. L., et al. (2007). Role of primary human alveolar epithelial cells in host defense against PubMed DOI PMC

Golovliov I., Baranov V., Krocova Z., Kovarova H., Sjöstedt A. (2003). An attenuated strain of the facultative intracellular bacterium PubMed DOI PMC

Gunn J. S., Ernst R. K. (2007). The structure and function of Francisella lipopolysaccharide. Ann. N.Y. Acad. Sci. 1105, 202–218. 10.1196/annals.1409.006 PubMed DOI PMC

Hajjar A. M., Harvey M. D., Shaffer S. A., Goodlett D. R., Sjöstedt A., Edebro H., et al. (2006). Lack of PubMed DOI PMC

Hall J. D., Woolard M. D., Gunn B. M., Craven R. R., Taft-Benz S., Frelinger J. A., et al. (2008). Infected-host-cell repertoire and cellular response in the lung following inhalation of PubMed DOI PMC

Henry T., Brotcke A., Weiss D. S., Thompson L. J., Monack D. M. (2007). Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J. Exp. Med. 204, 987–994. 10.1084/jem.20062665 PubMed DOI PMC

Heuston S., Begley M., Gahan C. G., Hill C. (2012). Isoprenoid biosynthesis in bacterial pathogens. Microbiology 158, 1389–1401. 10.1099/mic.0.051599-0 PubMed DOI

Holland K. M., Rosa S. J., Hazlett K. R. (2016). PubMed DOI PMC

Hong K. J., Wickstrum J. R., Yeh H. W., Parmely M. J. (2007). Toll-like receptor 2 controls the gamma interferon response to PubMed DOI PMC

Horng T., Barton G. M., Flavell R. A., Medzhitov R. (2002). The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420, 329–333. 10.1038/nature01180 PubMed DOI

Horng T., Barton G. M., Medzhitov R. (2001). TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2, 835–841. 10.1038/ni0901-835 PubMed DOI

Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D. R., et al. (2009). AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514–518. 10.1038/nature07725 PubMed DOI PMC

Hotson A. N., Gopinath S., Nicolau M., Khasanova A., Finck R., Monack D., et al. (2016). Coordinate actions of innate immune responses oppose those of the adaptive immune system during Salmonella infection of mice. Sci. Signal. 9, ra4. 10.1126/scisignal.aaa9303 PubMed DOI

Huang S., Gilfillan S., Cella M., Miley M. J., Lantz O., Lybarger L., et al. (2005). Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J. Biol. Chem. 280, 21183–21193. 10.1074/jbc.M501087200 PubMed DOI

Ishikawa H., Barber G. N. (2008). STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674–678. 10.1038/nature07317 PubMed DOI PMC

Ishikawa H., Ma Z., Barber G. N. (2009). STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788–792. 10.1038/nature08476 PubMed DOI PMC

Jin L., Hill K. K., Filak H., Mogan J., Knowles H., Zhang B., et al. (2011). MPYS is required for IRF3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers c-di-AMP and c-di-GMP. J. Immunol. 187, 2595–2601. 10.4049/jimmunol.1100088 PubMed DOI PMC

Jin T., Xiao T. S. (2015). Activation and assembly of the inflammasomes through conserved protein domain families. Apoptosis 20, 151–156. 10.1007/s10495-014-1053-5 PubMed DOI PMC

Jones C. L., Weiss D. S. (2011). TLR2 signaling contributes to rapid inflammasome activation during PubMed DOI PMC

Jones J. W., Kayagaki N., Broz P., Henry T., Newton K., O'Rourke K., et al. (2010). Absent in melanoma 2 is required for innate immune recognition of PubMed DOI PMC

Katz J., Zhang P., Martin M., Vogel S. N., Michalek S. M. (2006). Toll-like receptor 2 is required for inflammatory responses to PubMed DOI PMC

Kennedy A. D., DeLeo F. R. (2009). Neutrophil apoptosis and the resolution of infection. Immunol. Res. 43, 25–61. 10.1007/s12026-008-8049-6 PubMed DOI

Kim Y. K., Shin J. S., Nahm M. H. (2016). NOD-like receptors in infection, immunity, and diseases. Yonsei Med. J. 57, 5–14. 10.3349/ymj.2016.57.1.5 PubMed DOI PMC

Kingry L. C., Petersen J. M. (2014). Comparative review of PubMed DOI PMC

Kjer-Nielsen L., Patel O., Corbett A. J., Le Nours J., Meehan B., Liu L., et al. (2012). MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491, 717–723. 10.1038/nature11605 PubMed DOI

Kobayashi S. D., Braughton K. R., Whitney A. R., Voyich J. M., Schwan T. G., Musser J. M., et al. (2003). Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc. Natl. Acad. Sci. U.S.A. 100, 10948–10953. 10.1073/pnas.1833375100 PubMed DOI PMC

Kubelkova K., Benuchova M., Kozakova H., Sinkora M., Krocova Z., Pejchal J., et al. (2016). Gnotobiotic mouse model's contribution to understanding host-pathogen interactions. Cell. Mol. Life Sci. 73, 3961–3969. 10.1007/s00018-016-2341-8 PubMed DOI PMC

Law H. T., Lin A. E. S., Kim Y., Quach B., Nano F. E., Guttman J. A. (2011). PubMed DOI PMC

Li H., Nookala S., Bina X. R., Bina J. E., Re F. (2006). Innate immune response to PubMed DOI

Libich J. (1981). Tularémie. Prague: Avicenum.

Lindemann S. R., McLendon M. K., Apicella M. A., Jones B. D. (2007). An PubMed DOI PMC

Löfgren S., Tärnvik A., Bloom G. D., Sjöberg W. (1983). Phagocytosis and killing of PubMed PMC

Lord K. A., Hoffman-Liebermann B., Liebermann D. A. (1990). Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene 5, 1095–1097. PubMed

Lu Y. C., Yeh W. C., Ohashi P. S. (2008). LPS/TLR4 signal transduction pathway. Cytokine 42, 145–151. 10.1016/j.cyto.2008.01.006 PubMed DOI

Macela A., Stulik J., Hernychova L., Kroca M., Krocova Z., Kovarova H. (1996). The immune response against PubMed DOI

Maeshima N., Fernandez R. C. (2013). Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front. Cell. Infect. Microbiol. 3:3. 10.3389/fcimb.2013.00003 PubMed DOI PMC

Malik M., Bakshi C. S., Sahay B., Shah A., Lotz S. A., Sellati T. J. (2006). Toll-like receptor 2 is required for control of pulmonary infection with PubMed DOI PMC

Man S. M., Kanneganti T. D. (2015). Regulation of inflammasome activation. Immunol. Rev. 265, 6–21. 10.1111/imr.12296 PubMed DOI PMC

Man S. M., Karki R., Kanneganti T. D. (2016a). AIM2 inflammasome in infection, cancer, and autoimmunity: role in DNA sensing, inflammation, and innate immunity. Eur. J. Immunol. 46, 269–280. 10.1002/eji.201545839 PubMed DOI PMC

Man S. M., Karki R., Malireddi R. K., Neale G., Vogel P., Yamamoto M., et al. (2015). The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection. Nat. Immunol. 16, 467–475. 10.1038/ni.3118 PubMed DOI PMC

Man S. M., Karki R., Sasai M., Place D. E., Kesavardhana S., Temirov J., et al. (2016b). IRGB10 liberates bacterial ligands for sensing by the AIM2 and Caspase-11-NLRP3 inflammasomes. Cell 167, 382–396.e17. 10.1016/j.cell.2016.09.012 PubMed DOI PMC

Mariathasan S., Weiss D. S., Dixit V. M., Monack D. M. (2005). Innate immunity against PubMed DOI PMC

Marohn M. E., Barry E. M. (2013). Live attenuated tularemia vaccines: recent developments and future goals. Vaccine 31, 3485–3491. 10.1016/j.vaccine.2013.05.096 PubMed DOI PMC

McCaffrey R. L., Allen L.-A. H. (2006). PubMed DOI PMC

Miller D. K., Ayala J. M., Egger L. A., Raju S. M., Yamin T. T., Ding G. J., et al. (1993). Purification and characterization of active human interleukin-1 beta-converting enzyme from THP.1 monocytic cells. J. Biol. Chem. 268, 18062–18069. PubMed

Morita C. T., Jin C., Sarikonda G., Wang H. (2007). Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 215, 59–76. 10.1111/j.1600-065X.2006.00479.x PubMed DOI

Moser B., Eberl M. (2011). γδ T-APCs: a novel tool for immunotherapy? Cell. Mol. Life Sci. 68, 2443–2452. 10.1007/s00018-011-0706-6 PubMed DOI PMC

Nunes-Alves C., Booty M. G., Carpenter S. M., Jayaraman P., Rothchild A. C., Behar S. M. (2014). In search of a new paradigm for protective immunity to TB. Nat. Rev. Microbiol. 12, 289–299. 10.1038/nrmicro3230 PubMed DOI PMC

Nutter J. E., Myrvik Q. N. (1966). PubMed PMC

Okan N. A., Kasper D. L. (2013). The atypical lipopolysaccharide of Francisella. Carbohydr. Res. 378, 79–83. 10.1016/j.carres.2013.06.015 PubMed DOI PMC

O'Neill L. A., Golenbock D., Bowie A. G. (2013). The history of Toll-like receptors - redefining innate immunity. Nat. Rev. Immunol. 13, 453–460. 10.1038/nri3446 PubMed DOI

Park B. S., Lee J. O. (2013). Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp. Mol. Med. 45:e66. 10.1038/emm.2013.97 PubMed DOI PMC

Parsa K. V., Butchar J. P., Rajaram M. V., Cremer T. J., Gunn J. S., Schlesinger L. S., et al. (2008). Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNgamma response. Mol. Immunol. 45, 3428–3437. 10.1016/j.molimm.2008.04.006 PubMed DOI PMC

Pierini L. M. (2006). Uptake of serum-opsonized PubMed DOI

Plzakova L., Krocova Z., Kubelkova K., Macela A. (2015). Entry of PubMed DOI PMC

Plzakova L., Kubelkova K., Krocova Z., Zarybnicka L., Sinkorova Z., Macela A. (2014). B cell subsets are activated and produce cytokines during early phases of PubMed DOI

Poquet Y., Kroca M., Halary F., Stenmark S., Peyrat M. A., Bonneville M., et al. (1998). Expansion of Vγ9Vδ2 T cells is triggered by PubMed PMC

Putzova D., Senitkova I., Stulik J. (2016). Tularemia vaccines. Folia Microbiol. 61, 495–504. 10.1007/s12223-016-0461-z PubMed DOI

Rennert K., Otto P., Funke H., Huber O., Tomaso H., Mosig A. S. (2016). A human macrophage-hepatocyte co-culture model for comparative studies of infection and replication of PubMed DOI PMC

Richard K., Vogel S. N., Perkins D. J. (2016). Type I interferon licenses enhanced innate recognition and transcriptional responses to PubMed DOI PMC

Roberts L. M., Tuladhar S., Steele S. P., Riebe K. J., Chen C. J., Cumming R. I., et al. (2014). Identification of early interactions between Francisella and the host. Infect. Immun. 82, 2504–2510. 10.1128/IAI.01654-13 PubMed DOI PMC

Rothchild A. C., Sissons J. R., Shafiani S., Plaisier C., Min D., Mai D., et al. (2016). MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to PubMed DOI PMC

Rowland C. A., Hartley M. G., Flick-Smith H., Laws T. R., Eyles J. E., Oyston P. C. (2012). Peripheral human γδ T cells control growth of both avirulent and highly virulent strains of PubMed DOI

Russo B. C., Brown M. J., Nau G. J. (2013). MyD88-dependent signaling prolongs survival and reduces bacterial burden during pulmonary infection with virulent PubMed DOI PMC

Sandström G., Sjöstedt A., Johansson T., Kuoppa K., Williams J. C. (1992). Immunogenicity and toxicity of lipopolysaccharide from PubMed DOI

Santic M., Asare R., Skrobonja I., Jones S., Abu Kwaik Y. (2008). Acquisition of the vacuolar ATPase proton pump and phagosome acidification are essential for escape of PubMed DOI PMC

Santic M., Molmeret M., Klose K. E., Jones S., Kwaik Y. A. (2005). The PubMed DOI

Schulert G. S., Allen L. A. (2006). Differential infection of mononuclear phagocytes by PubMed DOI PMC

Schwartz J. T., Barker J. H., Kaufman J., Fayram D. C., McCracken J. M., Allen L. A. (2012a). PubMed DOI PMC

Schwartz J. T., Barker J. H., Long M. E., Kaufman J., McCracken J., Allen L.-A. H. (2012b). Natural IgM mediates complement-dependent uptake of PubMed DOI PMC

Sicard H., Fournie J. J. (2000). Metabolic routes as targets for immunological discrimination of host and parasite. Infect. Immun. 68, 4375–4377. 10.1128/IAI.68.8.4375-4377.2000 PubMed DOI PMC

Steele S., Radlinski L., Taft-Benz S., Brunton J., Kawula T. H. (2016). Trogocytosis-associated cell to cell spread of intracellular bacterial pathogens. Elife 5:e10625. 10.7554/eLife.10625 PubMed DOI PMC

Storek K. M., Gertsvolf N. A., Ohlson M. B., Monack D. M. (2015). cGAS and Ifi204 cooperate to produce type I IFNs in response to Francisella infection. J. Immunol. 194, 3236–3245. 10.4049/jimmunol.1402764 PubMed DOI PMC

Sun L., Wu J., Du F., Chen X., Chen Z. J. (2013). Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786–791. 10.1126/science.1232458 PubMed DOI PMC

Takaoka A., Wang Z., Choi M. K., Yanai H., Negishi H., Ban T., et al. (2007). DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501–505. 10.1038/nature06013 PubMed DOI

Telepnev M., Golovliov I., Grundström T., Tärnvik A., Sjöstedt A. (2003). PubMed DOI

Thornberry N. A., Bull H. G., Calaycay J. R., Chapman K. T., Howard A. D., Kostura M. J., et al. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768–774. 10.1038/356768a0 PubMed DOI

Thorpe B. D., Marcus S. (1964a). Phagocytosis and intracellular fate of PubMed

Thorpe B. D., Marcus S. (1964b). Phagocytosis and intracellular fate of PubMed

Tyler C. J., Doherty D. G., Moser B., Eberl M. (2015). Human Vγ9/Vδ2 T cells: innate adaptors of the immune system. Cell. Immunol. 296, 10–21. 10.1016/j.cellimm.2015.01.008 PubMed DOI

Udgata A., Qureshi R., Mukhopadhyay S. (2016). Transduction of functionally contrasting signals by two Mycobacterial PPE proteins downstream of TLR2 receptors. J. Immunol. 197, 1776–1787. 10.4049/jimmunol.1501816 PubMed DOI

Unterholzner L. (2013). The interferon response to intracellular DNA: why so many receptors? Immunobiology 218, 1312–1321. 10.1016/j.imbio.2013.07.007 PubMed DOI

Unterholzner L., Keating S. E., Baran M., Horan K. A., Jensen S. B., Sharma S., et al. (2010). IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11, 997–1004. 10.1038/ni.1932 PubMed DOI PMC

Veeranki S., Choubey D. (2012). Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization. Mol. Immunol. 49, 567–571. 10.1016/j.molimm.2011.11.004 PubMed DOI PMC

Warner N., Núñez G. (2013). MyD88: a critical adaptor protein in innate immunity signal transduction. J. Immunol. 190, 3–4. 10.4049/jimmunol.1203103 PubMed DOI

Wilson K. P., Black J. A., Thomson J. A., Kim E. E., Griffith J. P., Navia M. A., et al. (1994). Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370, 270–275. 10.1038/370270a0 PubMed DOI

Wu J., Sun L., Chen X., Du F., Shi H., Chen C., et al. (2013). Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826–830. 10.1126/science.1229963 PubMed DOI PMC

Xiao T. S. (2015). The nucleic acid-sensing inflammasomes. Immunol. Rev. 265, 103–111. 10.1111/imr.12281 PubMed DOI PMC

Zheng H., Tan Z., Zhou T., Zhu F., Ding Y., Liu T., et al. (2015). The TLR2 is activated by sporozoites and suppresses intrahepatic rodent malaria parasite development. Sci. Rep. 5:18239. 10.1038/srep18239 PubMed DOI PMC

Francisella and Antibodies

Early infection-induced natural antibody response

Innate Immune Recognition: An Issue More Complex Than Expected